Blood Glucose Meters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Blood Glucose Meters Pipeline Market Report Overview

A blood glucose meter is an electronic diabetic management device used for measuring blood glucose levels. The blood glucose meters pipeline market research report provides comprehensive information about the Blood glucose meters pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Key Segments ·       Continuous Glucose Monitors

·       Continuous Glucose Monitors – Sensors

·       Traditional Glucose Meters

Key Territories ·       The US

·       Europe

·       China

·       Australia

·       India

Key Regulatory Paths ·       510(k)

·       PMA

·       CE

·       NMPA

·       TGA

Leading Companies ·       4a Medicom GmbH

·       Abbott Diabetes Care Inc

·       Abbott Healthcare Pvt Ltd

·       Abbott Laboratories

·       Actxa Pte Ltd

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Blood Glucose Meters Pipeline Market by Segments

The key segments in the blood glucose meters market are continuous glucose monitors, continuous glucose monitors – sensors, and Traditional glucose meters. As of June 2023, the continuous glucose monitors segment had the highest number of pipeline products.

Blood Glucose Meters Pipeline Market Analysis by Segments, 2023 (%)

Blood Glucose Meters Pipeline Market Analysis by Segments, 2023 (%)

For more segment insights into the Blood glucose meters pipeline market, download a free report sample

Blood Glucose Meters Pipeline Market Segmentation by Territories

Some of the key territories in the blood glucose meters market are the US, Europe, China, Australia, and India among others. As of June 2023, the US had the highest number of pipeline products.

Blood Glucose Meters Pipeline Market Analysis by Territories, 2023 (%)

Blood Glucose Meters Pipeline Market Analysis by Territories, 2023 (%)

For more territory insights into the Blood glucose meters pipeline market, download a free report sample

Blood Glucose Meters Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths in the Blood glucose meters pipeline market are 510(k), PMA, CE, NMPA, and TGA among others. As of June 2023, 510(k) was the most followed pathway for pipeline products.

Blood Glucose Meters Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Blood Glucose Meters Pipeline Market Analysis by Regulatory Paths, 2023 (%)

For more regulatory path insights into the Blood glucose meters pipeline market, download a free report sample

Blood Glucose Meters Pipeline Market – Competitive Landscape

Some of the key companies in the blood glucose meters pipeline market are 4a Medicom GmbH, Abbott Diabetes Care Inc, Abbott Healthcare Pvt Ltd, Abbott Laboratories, and Actxa Pte Ltd among others.

Abbott Laboratories: Abbott Diabetes Care Inc (ADC), formerly TheraSense Inc, a subsidiary of Abbott Laboratories, is a medical device company that discovers, develops, manufactures, and markets pharmaceuticals and medical products for personal use and hospital use. The company’s products include glucose monitoring systems, diagnostics, medical devices, nutritionals, generic pharmaceuticals, and diabetes products. Its other products include barcode readers, removable test strips, port modules, testing strips, precision insulin systems, and precision glucose test strips. ADC also provides slim and ultra-lightweight meters, over-the-counter test strips, and simple blood glucose and ketone testing meters, glucose reading meters, among others. The company has a presence in the US, the Americas, Africa, Asia Pacific, and the Middle East.

Leading Blood Glucose Meters Pipeline Companies, 2023 (%)

Leading Blood Glucose Meters Pipeline Companies, 2023 (%)

For more company insights into the Blood glucose meters pipeline market, download a free report sample

Segments Covered in the Report

Blood Glucose Meters Pipeline Market Segments Outlook

  • Continuous Glucose Monitors
  • Continuous Glucose Monitors – Sensors
  • Traditional Glucose Meters

Blood Glucose Meters Pipeline Market Territories Outlook

  • The US
  • Europe
  • China
  • Australia
  • India

Blood Glucose Meters Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • PMA
  • CE
  • NMPA
  • TGA

Scope

This report provides:

  • Extensive coverage of the blood glucose meters under development.
  • Details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities.
  • Reviews of the major players involved in the development of blood glucose meters and lists of all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage.
  • Key clinical trial data of ongoing trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of Blood glucose meters under development.
  • Develop market-entry and market expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

4a Medicom GmbH
Abbott Diabetes Care Inc
Abbott Healthcare Pvt Ltd
Abbott Laboratories
Actxa Pte Ltd
Advanced Biosensors-Ohio LLC
Advanced Medical Electronics Corp
Afon Technology Ltd
Alertgy Inc
ALR Technologies Inc
Arkal Medical Inc (Inactive)
Azurite Technologies, Inc. (Inactive)
Bar-Ilan University
Baylor University
Biofi Medical Healthcare Pvt Ltd
BioGliko Sp zoo
Biolinq Inc
Biopeak Corp
Biorasis Inc
BioTex Inc
Biovotion AG
Brain Beat Ltd
Brigham and Women's Hospital
Brighter AB
CALISTO MEDICAL, INC. (Inactive)
Callitas Therapeutics Inc
Cardiff University
CGM3 Ltd
Cirtec Medical Corp
City, University of London
Columbia University
ConvaTec Group Plc
Co-Optical Inc
Cyber Medical Ltd (Inactive)
DexCom Inc
DiaMonTech GmbH
DirectSens GmbH
Echo Therapeutics Inc
Ecole Polytechnique Federale de Lausanne
eLutions Integrated Systems, Inc.
Emperra GmbH E-Health Technologies
EyeSense GmbH
Firefly Health Pty Ltd
Flowsion A/S
Gili Medical Ltd
Globe Medical Tech Inc (Inactive)
GlucoLight Corporation (Inactive)
GlucoMe Ltd
Glucometrix AG
GlucoModicum Oy
Glucorecs
GlucoRx Ltd
Glucosat
Glucosense Diagnostics Ltd (Inactive)
GlucoSet AS
GlucoStats System Pte Ltd.
GlucoTrack Inc
Glucovation Inc
GluMetrics Inc
Glusense Ltd
GlySens Inc
G-Sense Ltd.
Guangzhou Powder Pharmaceuticals Ltd
Guided Therapeutics Inc
Hagar Tech
Helo Corp
iGlyko, Inc. (Inactive)
Indigo Diabetes NV
InLight Solutions Inc.
Innopharmax Inc
Innovosens AB
Integrated Medical Sensors
IntelliDx Inc (Inactive)
InventHelp
Invivomon Inc (Inactive)
Invivosense ASA (Inactive)
I-Sens Inc
iSense Corporation (Inactive)
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
KeenCAT Technologies
Keratin Biosciences Inc
Know Labs Inc
KTH Royal Institute of Technology
Lein Applied Diagnostics Limited
LEMM Technologies, LLC
Lifecare AS
LifeScan Inc
Light Touch Technology Co Ltd
LighTouch Medical, Inc.
Luminous Medical Inc (Inactive)
Lyte Labs
Massachusetts Institute of Technology
Medical Wireless Sensing Ltd
Medtronic MiniMed Inc
Medtronic Plc
Mellitor Ltd
Metronom Health Inc
MicroTech Medical Co Ltd
mobiLIFE
Mologic Ltd
Movano Inc
Nagasaki University
Nemaura Medical Inc
Newton Photonics Inc
NIR Diagnostics Inc. (Inactive)
Northwestern University
Occuity Ltd
Pelikan Technologies, Inc. (Inactive)
Pepex Biomedical, Inc.
PharmaTech Solutions Inc
PKvitality SAS
POPS! Diabetes Care Inc
PositiveID Corp
Profusa Inc
Provigate Inc
Purdue University
Q Step Technologies, Inc.
Quantum Operation Co Ltd
Roche Diabetes Care Inc
Sangui BioTech International Inc
Sanmina Corp
SD Biosensor Inc
Senseonics Holdings Inc
SensiVida Medical Technologies, Inc. (Inactive)
Sensys Medical, Inc.
Sentec Pte Ltd
Shenzhen Refresh Biosensing Technology Co Ltd
Shenzhen Sibionics Technology Co Ltd
Shield Diagnostics
Singapore Biomicro Pte Ltd
Socrates Health Solutions, Inc.
Solys Diagnostics Inc
Spire Biophotonics Lifesciences
St. Louis Medical Devices Inc (Inactive)
Stony Brook University
Swansea University
Tandem Diabetes Care Inc
TecMed Inc
Tenax Therapeutics Inc
Terumo Corp
Texas A&M University
Tonwo Health Clinic Technology Pty Ltd
Ultradian Diagnostics LLC
Umana Medical Technologies Ltd
University of Bordeaux
University of California Berkeley
University of California Irvine
University of California San Diego
University of Central Florida
University of South Carolina
University of South Florida
University of Technology Sydney
University of Texas at Arlington
Uxn Co Ltd
VeriTeQ Corporation
Virginia Commonwealth University
VivaLyf Innovations Pvt Ltd
Vytrace, Inc.
Weglo
Weitai Medical Equipment (Hangzhou) Co Ltd
Xcellence in Bio Innovations & Technologies Pvt Ltd
Zansors LLC
Zyvex Corp

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 11

|1.2 List of Figures 23

2 Introduction 24

2.1 Blood Glucose Meters Overview 24

3 Products under Development 25

3.1 Blood Glucose Meters – Pipeline Products by Stage of Development 25

3.2 Blood Glucose Meters – Pipeline Products by Segment 26

3.3 Blood Glucose Meters – Pipeline Products by Territory 27

3.4 Blood Glucose Meters – Pipeline Products by Regulatory Path 29

3.5 Blood Glucose Meters – Pipeline Products by Estimated Approval Date 30

3.6 Blood Glucose Meters – Ongoing Clinical Trials 31

4 Blood Glucose Meters – Pipeline Products under Development by Companies 32

4.1 Blood Glucose Meters Companies – Pipeline Products by Stage of Development 32

4.2 Blood Glucose Meters – Pipeline Products by Stage of Development 38

5 Blood Glucose Meters Companies and Product Overview 44

5.1 4a Medicom GmbH Company Overview 44

5.1.1 4a Medicom GmbH Pipeline Products & Ongoing Clinical Trials Overview 44

5.2 Abbott Diabetes Care Inc Company Overview 45

5.2.1 Abbott Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 45

5.3 Abbott Healthcare Pvt Ltd Company Overview 49

5.3.1 Abbott Healthcare Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 49

5.4 Abbott Laboratories Company Overview 50

5.4.1 Abbott Laboratories Pipeline Products & Ongoing Clinical Trials Overview 50

5.5 Actxa Pte Ltd Company Overview 52

5.5.1 Actxa Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 52

5.6 Advanced Biosensors-Ohio LLC Company Overview 54

5.6.1 Advanced Biosensors-Ohio LLC Pipeline Products & Ongoing Clinical Trials Overview 54

5.7 Advanced Medical Electronics Corp Company Overview 55

5.7.1 Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview 55

5.8 Afon Technology Ltd Company Overview 56

5.8.1 Afon Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 56

5.9 Alertgy Inc Company Overview 59

5.9.1 Alertgy Inc Pipeline Products & Ongoing Clinical Trials Overview 59

5.10 ALR Technologies Inc Company Overview 60

5.10.1 ALR Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 60

5.11 Arkal Medical Inc (Inactive) Company Overview 61

5.11.1 Arkal Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 61

5.12 Azurite Technologies, Inc. (Inactive) Company Overview 62

5.12.1 Azurite Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 62

5.13 Bar-Ilan University Company Overview 63

5.13.1 Bar-Ilan University Pipeline Products & Ongoing Clinical Trials Overview 63

5.14 Baylor University Company Overview 64

5.14.1 Baylor University Pipeline Products & Ongoing Clinical Trials Overview 64

5.15 Biofi Medical Healthcare Pvt Ltd Company Overview 65

5.15.1 Biofi Medical Healthcare Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 65

5.16 BioGliko Sp zoo Company Overview 66

5.16.1 BioGliko Sp zoo Pipeline Products & Ongoing Clinical Trials Overview 66

5.17 Biolinq Inc Company Overview 67

5.17.1 Biolinq Inc Pipeline Products & Ongoing Clinical Trials Overview 67

5.18 Biopeak Corp Company Overview 68

5.18.1 Biopeak Corp Pipeline Products & Ongoing Clinical Trials Overview 68

5.19 Biorasis Inc Company Overview 69

5.19.1 Biorasis Inc Pipeline Products & Ongoing Clinical Trials Overview 69

5.20 BioTex Inc Company Overview 70

5.20.1 BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview 70

5.21 Biovotion AG Company Overview 71

5.21.1 Biovotion AG Pipeline Products & Ongoing Clinical Trials Overview 71

5.22 Brain Beat Ltd Company Overview 72

5.22.1 Brain Beat Ltd Pipeline Products & Ongoing Clinical Trials Overview 72

5.23 Brigham and Women’s Hospital Company Overview 73

5.23.1 Brigham and Women’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 73

5.24 Brighter AB Company Overview 74

5.24.1 Brighter AB Pipeline Products & Ongoing Clinical Trials Overview 74

5.25 CALISTO MEDICAL, INC. (Inactive) Company Overview 75

5.25.1 CALISTO MEDICAL, INC. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 75

5.26 Callitas Therapeutics Inc Company Overview 76

5.26.1 Callitas Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 76

5.27 Cardiff University Company Overview 77

5.27.1 Cardiff University Pipeline Products & Ongoing Clinical Trials Overview 77

5.28 CGM3 Ltd Company Overview 78

5.28.1 CGM3 Ltd Pipeline Products & Ongoing Clinical Trials Overview 78

5.29 Cirtec Medical Corp Company Overview 79

5.29.1 Cirtec Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 79

5.30 City, University of London Company Overview 80

5.30.1 City, University of London Pipeline Products & Ongoing Clinical Trials Overview 80

5.31 Columbia University Company Overview 81

5.31.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 81

5.32 ConvaTec Group Plc Company Overview 82

5.32.1 ConvaTec Group Plc Pipeline Products & Ongoing Clinical Trials Overview 82

5.33 Co-Optical Inc Company Overview 83

5.33.1 Co-Optical Inc Pipeline Products & Ongoing Clinical Trials Overview 83

5.34 Cyber Medical Ltd (Inactive) Company Overview 84

5.34.1 Cyber Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 84

5.35 DexCom Inc Company Overview 85

5.35.1 DexCom Inc Pipeline Products & Ongoing Clinical Trials Overview 85

5.36 DiaMonTech GmbH Company Overview 92

5.36.1 DiaMonTech GmbH Pipeline Products & Ongoing Clinical Trials Overview 92

5.37 DirectSens GmbH Company Overview 94

5.37.1 DirectSens GmbH Pipeline Products & Ongoing Clinical Trials Overview 94

5.38 Echo Therapeutics Inc Company Overview 95

5.38.1 Echo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 95

5.39 Ecole Polytechnique Federale de Lausanne Company Overview 99

5.39.1 Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview 99

5.40 eLutions Integrated Systems, Inc. Company Overview 100

5.40.1 eLutions Integrated Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 100

5.41 Emperra GmbH E-Health Technologies Company Overview 101

5.41.1 Emperra GmbH E-Health Technologies Pipeline Products & Ongoing Clinical Trials Overview 101

5.42 EyeSense GmbH Company Overview 102

5.42.1 EyeSense GmbH Pipeline Products & Ongoing Clinical Trials Overview 102

5.43 Firefly Health Pty Ltd Company Overview 105

5.43.1 Firefly Health Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 105

5.44 Flowsion A/S Company Overview 106

5.44.1 Flowsion A/S Pipeline Products & Ongoing Clinical Trials Overview 106

5.45 Gili Medical Ltd Company Overview 107

5.45.1 Gili Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 107

5.46 Globe Medical Tech Inc (Inactive) Company Overview 108

5.46.1 Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 108

5.47 GlucoLight Corporation (Inactive) Company Overview 109

5.47.1 GlucoLight Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 109

5.48 GlucoMe Ltd Company Overview 110

5.48.1 GlucoMe Ltd Pipeline Products & Ongoing Clinical Trials Overview 110

5.49 Glucometrix AG Company Overview 111

5.49.1 Glucometrix AG Pipeline Products & Ongoing Clinical Trials Overview 111

5.50 GlucoModicum Oy Company Overview 112

5.50.1 GlucoModicum Oy Pipeline Products & Ongoing Clinical Trials Overview 112

5.51 Glucorecs Company Overview 113

5.51.1 Glucorecs Pipeline Products & Ongoing Clinical Trials Overview 113

5.52 GlucoRx Ltd Company Overview 114

5.52.1 GlucoRx Ltd Pipeline Products & Ongoing Clinical Trials Overview 114

5.53 Glucosat Company Overview 115

5.53.1 Glucosat Pipeline Products & Ongoing Clinical Trials Overview 115

5.54 Glucosense Diagnostics Ltd (Inactive) Company Overview 116

5.54.1 Glucosense Diagnostics Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 116

5.55 GlucoSet AS Company Overview 118

5.55.1 GlucoSet AS Pipeline Products & Ongoing Clinical Trials Overview 118

5.56 GlucoStats System Pte Ltd. Company Overview 119

5.56.1 GlucoStats System Pte Ltd. Pipeline Products & Ongoing Clinical Trials Overview 119

5.57 GlucoTrack Inc Company Overview 121

5.57.1 GlucoTrack Inc Pipeline Products & Ongoing Clinical Trials Overview 121

5.58 Glucovation Inc Company Overview 126

5.58.1 Glucovation Inc Pipeline Products & Ongoing Clinical Trials Overview 126

5.59 GluMetrics Inc Company Overview 127

5.59.1 GluMetrics Inc Pipeline Products & Ongoing Clinical Trials Overview 127

5.60 Glusense Ltd Company Overview 128

5.60.1 Glusense Ltd Pipeline Products & Ongoing Clinical Trials Overview 128

5.61 GlySens Inc Company Overview 131

5.61.1 GlySens Inc Pipeline Products & Ongoing Clinical Trials Overview 131

5.62 G-Sense Ltd. Company Overview 136

5.62.1 G-Sense Ltd. Pipeline Products & Ongoing Clinical Trials Overview 136

5.63 Guangzhou Powder Pharmaceuticals Ltd Company Overview 137

5.63.1 Guangzhou Powder Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview 137

5.64 Guided Therapeutics Inc Company Overview 138

5.64.1 Guided Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 138

5.65 Hagar Tech Company Overview 139

5.65.1 Hagar Tech Pipeline Products & Ongoing Clinical Trials Overview 139

5.66 Helo Corp Company Overview 143

5.66.1 Helo Corp Pipeline Products & Ongoing Clinical Trials Overview 143

5.67 iGlyko, Inc. (Inactive) Company Overview 144

5.67.1 iGlyko, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 144

5.68 Indigo Diabetes NV Company Overview 145

5.68.1 Indigo Diabetes NV Pipeline Products & Ongoing Clinical Trials Overview 145

5.69 InLight Solutions Inc. Company Overview 146

5.69.1 InLight Solutions Inc. Pipeline Products & Ongoing Clinical Trials Overview 146

5.70 Innopharmax Inc Company Overview 147

5.70.1 Innopharmax Inc Pipeline Products & Ongoing Clinical Trials Overview 147

5.71 Innovosens AB Company Overview 148

5.71.1 Innovosens AB Pipeline Products & Ongoing Clinical Trials Overview 148

5.72 Integrated Medical Sensors Company Overview 149

5.72.1 Integrated Medical Sensors Pipeline Products & Ongoing Clinical Trials Overview 149

5.73 IntelliDx Inc (Inactive) Company Overview 150

5.73.1 IntelliDx Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 150

5.74 InventHelp Company Overview 151

5.74.1 InventHelp Pipeline Products & Ongoing Clinical Trials Overview 151

5.75 Invivomon Inc (Inactive) Company Overview 152

5.75.1 Invivomon Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 152

5.76 Invivosense ASA (Inactive) Company Overview 153

5.76.1 Invivosense ASA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 153

5.77 I-Sens Inc Company Overview 154

5.77.1 I-Sens Inc Pipeline Products & Ongoing Clinical Trials Overview 154

5.78 iSense Corporation (Inactive) Company Overview 156

5.78.1 iSense Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 156

5.79 Jiangsu Yuyue Medical Equipment & Supply Co Ltd Company Overview 157

5.79.1 Jiangsu Yuyue Medical Equipment & Supply Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 157

5.80 KeenCAT Technologies Company Overview 158

5.80.1 KeenCAT Technologies Pipeline Products & Ongoing Clinical Trials Overview 158

5.81 Keratin Biosciences Inc Company Overview 159

5.81.1 Keratin Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 159

5.82 Know Labs Inc Company Overview 160

5.82.1 Know Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 160

5.83 KTH Royal Institute of Technology Company Overview 162

5.83.1 KTH Royal Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 162

5.84 Lein Applied Diagnostics Limited Company Overview 163

5.84.1 Lein Applied Diagnostics Limited Pipeline Products & Ongoing Clinical Trials Overview 163

5.85 LEMM Technologies, LLC Company Overview 164

5.85.1 LEMM Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 164

5.86 Lifecare AS Company Overview 165

5.86.1 Lifecare AS Pipeline Products & Ongoing Clinical Trials Overview 165

5.87 LifeScan Inc Company Overview 166

5.87.1 LifeScan Inc Pipeline Products & Ongoing Clinical Trials Overview 166

5.88 Light Touch Technology Co Ltd Company Overview 168

5.88.1 Light Touch Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 168

5.89 LighTouch Medical, Inc. Company Overview 169

5.89.1 LighTouch Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 169

5.90 Luminous Medical Inc (Inactive) Company Overview 172

5.90.1 Luminous Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 172

5.91 Lyte Labs Company Overview 173

5.91.1 Lyte Labs Pipeline Products & Ongoing Clinical Trials Overview 173

5.92 Massachusetts Institute of Technology Company Overview 174

5.92.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 174

5.93 Medical Wireless Sensing Ltd Company Overview 176

5.93.1 Medical Wireless Sensing Ltd Pipeline Products & Ongoing Clinical Trials Overview 176

5.94 Medtronic MiniMed Inc Company Overview 177

5.94.1 Medtronic MiniMed Inc Pipeline Products & Ongoing Clinical Trials Overview 177

5.95 Medtronic Plc Company Overview 184

5.95.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 184

5.96 Mellitor Ltd Company Overview 187

5.96.1 Mellitor Ltd Pipeline Products & Ongoing Clinical Trials Overview 187

5.97 Metronom Health Inc Company Overview 188

5.97.1 Metronom Health Inc Pipeline Products & Ongoing Clinical Trials Overview 188

5.98 MicroTech Medical Co Ltd Company Overview 189

5.98.1 MicroTech Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 189

5.99 mobiLIFE Company Overview 194

5.99.1 mobiLIFE Pipeline Products & Ongoing Clinical Trials Overview 194

5.100 Mologic Ltd Company Overview 195

5.100.1 Mologic Ltd Pipeline Products & Ongoing Clinical Trials Overview 195

5.101 Movano Inc Company Overview 196

5.101.1 Movano Inc Pipeline Products & Ongoing Clinical Trials Overview 196

5.102 Nagasaki University Company Overview 197

5.102.1 Nagasaki University Pipeline Products & Ongoing Clinical Trials Overview 197

5.103 Nemaura Medical Inc Company Overview 198

5.103.1 Nemaura Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 198

5.104 Newton Photonics Inc Company Overview 202

5.104.1 Newton Photonics Inc Pipeline Products & Ongoing Clinical Trials Overview 202

5.105 NIR Diagnostics Inc. (Inactive) Company Overview 203

5.105.1 NIR Diagnostics Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 203

5.106 Northwestern University Company Overview 204

5.106.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 204

5.107 Occuity Ltd Company Overview 205

5.107.1 Occuity Ltd Pipeline Products & Ongoing Clinical Trials Overview 205

5.108 Pelikan Technologies, Inc. (Inactive) Company Overview 206

5.108.1 Pelikan Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 206

5.109 Pepex Biomedical, Inc. Company Overview 207

5.109.1 Pepex Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 207

5.110 PharmaTech Solutions Inc Company Overview 208

5.110.1 PharmaTech Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 208

5.111 PKvitality SAS Company Overview 211

5.111.1 PKvitality SAS Pipeline Products & Ongoing Clinical Trials Overview 211

5.112 POPS! Diabetes Care Inc Company Overview 214

5.112.1 POPS! Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 214

5.113 PositiveID Corp Company Overview 215

5.113.1 PositiveID Corp Pipeline Products & Ongoing Clinical Trials Overview 215

5.114 Profusa Inc Company Overview 216

5.114.1 Profusa Inc Pipeline Products & Ongoing Clinical Trials Overview 216

5.115 Provigate Inc Company Overview 217

5.115.1 Provigate Inc Pipeline Products & Ongoing Clinical Trials Overview 217

5.116 Purdue University Company Overview 219

5.116.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview 219

5.117 Q Step Technologies, Inc. Company Overview 221

5.117.1 Q Step Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 221

5.118 Quantum Operation Co Ltd Company Overview 222

5.118.1 Quantum Operation Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 222

5.119 Roche Diabetes Care Inc Company Overview 223

5.119.1 Roche Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 223

5.120 Sangui BioTech International Inc Company Overview 224

5.120.1 Sangui BioTech International Inc Pipeline Products & Ongoing Clinical Trials Overview 224

5.121 Sanmina Corp Company Overview 225

5.121.1 Sanmina Corp Pipeline Products & Ongoing Clinical Trials Overview 225

5.122 SD Biosensor Inc Company Overview 226

5.122.1 SD Biosensor Inc Pipeline Products & Ongoing Clinical Trials Overview 226

5.123 Senseonics Holdings Inc Company Overview 228

5.123.1 Senseonics Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 228

5.124 SensiVida Medical Technologies, Inc. (Inactive) Company Overview 232

5.124.1 SensiVida Medical Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 232

5.125 Sensys Medical, Inc. Company Overview 233

5.125.1 Sensys Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 233

5.126 Sentec Pte Ltd Company Overview 234

5.126.1 Sentec Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 234

5.127 Shenzhen Refresh Biosensing Technology Co Ltd Company Overview 235

5.127.1 Shenzhen Refresh Biosensing Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 235

5.128 Shenzhen Sibionics Technology Co Ltd Company Overview 236

5.128.1 Shenzhen Sibionics Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 236

5.129 Shield Diagnostics Company Overview 237

5.129.1 Shield Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 237

5.130 Singapore Biomicro Pte Ltd Company Overview 238

5.130.1 Singapore Biomicro Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 238

5.131 Socrates Health Solutions, Inc. Company Overview 239

5.131.1 Socrates Health Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 239

5.132 Solys Diagnostics Inc Company Overview 242

5.132.1 Solys Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 242

5.133 Spire Biophotonics Lifesciences Company Overview 243

5.133.1 Spire Biophotonics Lifesciences Pipeline Products & Ongoing Clinical Trials Overview 243

5.134 St. Louis Medical Devices Inc (Inactive) Company Overview 244

5.134.1 St. Louis Medical Devices Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 244

5.135 Stony Brook University Company Overview 245

5.135.1 Stony Brook University Pipeline Products & Ongoing Clinical Trials Overview 245

5.136 Swansea University Company Overview 246

5.136.1 Swansea University Pipeline Products & Ongoing Clinical Trials Overview 246

5.137 Tandem Diabetes Care Inc Company Overview 248

5.137.1 Tandem Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 248

5.138 TecMed Inc Company Overview 249

5.138.1 TecMed Inc Pipeline Products & Ongoing Clinical Trials Overview 249

5.139 Tenax Therapeutics Inc Company Overview 250

5.139.1 Tenax Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 250

5.140 Terumo Corp Company Overview 251

5.140.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 251

5.141 Texas A&M University Company Overview 253

5.141.1 Texas A&M University Pipeline Products & Ongoing Clinical Trials Overview 253

5.142 Tonwo Health Clinic Technology Pty Ltd Company Overview 254

5.142.1 Tonwo Health Clinic Technology Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 254

5.143 Ultradian Diagnostics LLC Company Overview 255

5.143.1 Ultradian Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 255

5.144 Umana Medical Technologies Ltd Company Overview 256

5.144.1 Umana Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 256

5.145 University of Bordeaux Company Overview 257

5.145.1 University of Bordeaux Pipeline Products & Ongoing Clinical Trials Overview 257

5.146 University of California Berkeley Company Overview 258

5.146.1 University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 258

5.147 University of California Irvine Company Overview 259

5.147.1 University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview 259

5.148 University of California San Diego Company Overview 260

5.148.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 260

5.149 University of Central Florida Company Overview 261

5.149.1 University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview 261

5.150 University of South Carolina Company Overview 262

5.150.1 University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview 262

5.151 University of South Florida Company Overview 263

5.151.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 263

5.152 University of Technology Sydney Company Overview 264

5.152.1 University of Technology Sydney Pipeline Products & Ongoing Clinical Trials Overview 264

5.153 University of Texas at Arlington Company Overview 265

5.153.1 University of Texas at Arlington Pipeline Products & Ongoing Clinical Trials Overview 265

5.154 Uxn Co Ltd Company Overview 266

5.154.1 Uxn Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 266

5.155 VeriTeQ Corporation Company Overview 272

5.155.1 VeriTeQ Corporation Pipeline Products & Ongoing Clinical Trials Overview 272

5.156 Virginia Commonwealth University Company Overview 273

5.156.1 Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview 273

5.157 VivaLyf Innovations Pvt Ltd Company Overview 274

5.157.1 VivaLyf Innovations Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 274

5.158 Vytrace, Inc. Company Overview 275

5.158.1 Vytrace, Inc. Pipeline Products & Ongoing Clinical Trials Overview 275

5.159 Weglo Company Overview 276

5.159.1 Weglo Pipeline Products & Ongoing Clinical Trials Overview 276

5.160 Weitai Medical Equipment (Hangzhou) Co Ltd Company Overview 277

5.160.1 Weitai Medical Equipment (Hangzhou) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 277

5.161 Xcellence in Bio Innovations & Technologies Pvt Ltd Company Overview 278

5.161.1 Xcellence in Bio Innovations & Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 278

5.162 Zansors LLC Company Overview 279

5.162.1 Zansors LLC Pipeline Products & Ongoing Clinical Trials Overview 279

5.163 Zyvex Corp Company Overview 280

5.163.1 Zyvex Corp Pipeline Products & Ongoing Clinical Trials Overview 280

6 Blood Glucose Meters- Recent Developments 281

6.1 Jul 05, 2023: Insulet to Announce Second Quarter 2023 Financial Results on August 8, 2023 281

6.2 Jun 20, 2023: Veravas Launches Groundbreaking VeraBIND Technology for Ultra-Sensitive Assays and Matrix Free Sample Analysis 281

6.3 May 26, 2023: Daewoong’s cumulative CGM sales exceed 600,000 units 282

6.4 May 16, 2023: Senzime Announces Bulletin from annual general meeting 282

6.5 May 15, 2023: Terumo announces consolidated financial results for the fiscal year ended March 31, 2023 283

6.6 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023 283

6.7 May 11, 2023: Sanmina posts results for fiscal Q2 ended April 1, 2023 284

6.8 May 11, 2023: Hundreds of children with type 2 diabetes to be offered choice of two life changing technologies 286

6.9 Apr 21, 2023: Invitation to Senzime’s first quarter 2023 report presentation 287

6.10 Apr 12, 2023: Medtronic has a layoff in California 287

6.11 Apr 10, 2023: Draper Names Sarah Leeper Vice President and General Manager for Electronic Systems 287

6.12 Apr 10, 2023: Henry Ford Health Appoints New Orthopedics Chair and Medical Director 288

6.13 Mar 29, 2023: Astellas and Roche partner on Bluestar integrated diabetes solution 289

6.14 Mar 28, 2023: EKF Diagnostics Holdings Announces its final results for the year ended 31 December 2022 289

6.15 Mar 22, 2023: ConvaTec Group Notice of Annual General Meeting 291

6.16 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company 291

6.17 Mar 09, 2023: ConvaTec Group Announces Annual Results for the twelve months ended 31 December 2022 292

6.18 Mar 09, 2023: New method for detecting nanoplastics in blood 293

6.19 Feb 24, 2023: Insulet Reports Full Year 2022 Revenue Increase of 19% and Fourth Quarter 2022 Revenue Increase of 20% Year-Over-Year 294

6.20 Feb 16, 2023: Henry Schein Reports Fourth-Quarter and Full-Year 2022 Financial Results and Introduces 2023 Financial Guidance 297

6.21 Feb 09, 2023: Sysmex Announces Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2023 300

6.22 Feb 09, 2023: Terumo Notice Concerning Revision of the Full-Year Financial Guidance for Fiscal Year Ending March 31, 2023 302

6.23 Feb 09, 2023: Terumo Corp Announces Consolidated Financial Results for the Third Quarter Ended December 31, 2022 302

6.24 Feb 09, 2023: BlueStar reduces systolic blood pressure in 42% of patients in Remote Patient Monitoring Program using cellular-enabled blood pressure monitors 303

6.25 Feb 08, 2023: Sysmex Corp. Notice of Changes in Representative Directors 304

6.26 Feb 08, 2023: The new prostate cancer blood test with 94 percent accuracy 305

6.27 Feb 02, 2023: F. Hoffmann-La Roche Announces Financial Results for fiscal 2022 305

6.28 Feb 01, 2023: Senzime Announces Interim report January-December 2022 305

6.29 Jan 30, 2023: Sanmina’s Announces First Quarter Fiscal 2023 Financial Results 307

6.30 Jan 26, 2023: Senzime’s Announces Invitation to fourth quarter 2022 report presentation 309

6.31 Jan 23, 2023: Senzime Notice of Extraordinary General Meeting 309

6.32 Jan 19, 2023: Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2022 Financial Results on February 22, 2023 311

6.33 Jan 12, 2023: Insulet to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023 312

6.34 Jan 04, 2023: Indigo Diabetes business update 312

6.35 Dec 13, 2022: Thomas Schinecker replaces Severin Schwan as Roche’s new CEO 313

6.36 Dec 08, 2022: Edwards Lifesciences Announces CEO Succession Plan 313

6.37 Dec 08, 2022: Edwards Lifesciences Announces CEO Succession Plan 314

6.38 Nov 30, 2022: A new self-powered ingestible sensor opens new avenues for gut research 315

6.39 Nov 23, 2022: Medtronic Reports Quarterly Earnings 316

6.40 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results 317

6.41 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday 322

6.42 Nov 10, 2022: Terumo Corp Announces Consolidated Financial Results for the Second Quarter Ended September 30, 2022 322

6.43 Nov 01, 2022: Henry Schein Reports Record Non-GAAP Third-Quarter 2022 Diluted EPS Financial Results 323

6.44 Oct 20, 2022: Edwards Lifesciences to Host Earnings Conference Call on October 27, 2022 325

6.45 Sep 22, 2022: Insulet to Announce Third Quarter 2022 Financial Results on November 3, 2022 325

6.46 Sep 22, 2022: MicroTech Medical Inc announced interim report for 2022 326

6.47 Sep 08, 2022: Robert G. Riney Named Henry Ford Health President and CEO 326

6.48 Sep 07, 2022: Medtronic to appear at September investor conferences 326

6.49 Sep 06, 2022: LifeScan Names Rekha Ramesh Chief Digital and Information Officer 326

6.50 Sep 05, 2022: Sanofi announce Evolution of the Board of Directors 327

6.51 Sep 01, 2022: Bayer Announces Appointment of Kimberly Mathisen to Supervisory Board 328

6.52 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results 328

6.53 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results 331

6.54 Aug 22, 2022: Tandem Diabetes Care Announces Upcoming Conference Presentations 334

6.55 Aug 20, 2022: Herbert Smith Freehills advises Sanofi on €300 million equity investment in Innovent 334

6.56 Aug 17, 2022: Senseonics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase 334

6.57 Aug 15, 2022: Nemaura Medical Reports Fiscal First Quarter 2023 Results and Provides Business Update 334

6.58 Aug 11, 2022: Henry Schein Announces the Passing of Board Member E. Dianne Rekow 335

6.59 Aug 11, 2022: Tenax Therapeutics announce results for the first Six Months of June 30, 2022 335

6.60 Aug 01, 2022: Sanmina reports financial results for fiscal Q3 ended July 2, 2022 336

6.61 Aug 01, 2022: Audrey Derveloy appointed President of Sanofi France 337

6.62 Jul 28, 2022: Sanofi’s half-year financial report for 2022 338

6.63 Jul 21, 2022: Edwards Lifesciences to Host Earnings Conference Call on July 28, 2022 338

6.64 Jul 21, 2022: Roche: Appointed Thomas Schinecker as New CEO Effective March 15, 2023 338

6.65 Jul 21, 2022: Nemaura Medical granted UK trademark “Meta Score,” a digital biomarker term for its metabolic health program 338

6.66 Jul 20, 2022: Abbott Reports Second-Quarter 2022 Results and Raises Full-Year EPS Guidance 338

6.67 Jul 12, 2022: Tandem Diabetes Care to Announce Second Quarter 2022 Financial Results on August 3 2022 339

6.68 Jul 12, 2022: Aspire & USF Pass $10M in ticket & donation revenue 339

7 Appendix 341

7.1 Methodology 341

7.2 About GlobalData 344

7.3 Contact Us 344

7.4 Disclaimer 344

Table

Blood Glucose Meters – Pipeline Products by Stage of Development 25

Blood Glucose Meters – Pipeline Products by Segment 26

Blood Glucose Meters – Pipeline Products by Territory 27

Blood Glucose Meters – Pipeline Products by Regulatory Path 29

Blood Glucose Meters – Pipeline Products by Estimated Approval Date 30

Blood Glucose Meters – Ongoing Clinical Trials 31

Blood Glucose Meters Companies – Pipeline Products by Stage of Development 32

Blood Glucose Meters – Pipeline Products by Stage of Development 38

4a Medicom GmbH Pipeline Products & Ongoing Clinical Trials Overview 44

GlucoPEARL – Product Status 44

GlucoPEARL – Product Description 44

Abbott Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 45

FreeStyle Libre Flash Glucose Monitoring System – Children – Product Status 45

FreeStyle Libre Flash Glucose Monitoring System – Children – Product Description 46

Fully Integrated Blood Glucose Monitoring System – Product Status 46

Fully Integrated Blood Glucose Monitoring System – Product Description 46

Modified FreeStyle Libre 2 Flash Glucose Monitoring Sensor – Pregnant Women – Product Status 47

Modified FreeStyle Libre 2 Flash Glucose Monitoring Sensor – Pregnant Women – Product Description 47

Modified FreeStyle Libre 3 Flash Glucose Monitoring Sensor – Pregnant Women – Product Status 47

Modified FreeStyle Libre 3 Flash Glucose Monitoring Sensor – Pregnant Women – Product Description 48

Updated Hospital Blood Glucose Monitoring System – Product Status 48

Updated Hospital Blood Glucose Monitoring System – Product Description 48

Abbott Healthcare Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 49

Lingo Glucose – Product Status 49

Lingo Glucose – Product Description 49

Abbott Laboratories Pipeline Products & Ongoing Clinical Trials Overview 50

Continuous Glucose-Ketone Monitoring System – Product Status 50

Continuous Glucose-Ketone Monitoring System – Product Description 51

Actxa Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 52

Actxa BGM Tracker (GLO2) – Product Status 52

Actxa BGM Tracker (GLO2) – Product Description 52

SVT In-Ear – Product Status 53

SVT In-Ear – Product Description 53

Advanced Biosensors-Ohio LLC Pipeline Products & Ongoing Clinical Trials Overview 54

My Medibit – Product Status 54

My Medibit – Product Description 54

Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview 55

Continuous Glucose Monitor – Product Status 55

Continuous Glucose Monitor – Product Description 55

Afon Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 56

Non-Invasive Blood Glucose Monitor – Product Status 56

Non-Invasive Blood Glucose Monitor – Product Description 56

Afon Technology Ltd – Ongoing Clinical Trials Overview 57

Non-Invasive Blood Glucose Monitor – Development Study to Undertake a Comprehensive Performance Evaluation of Prototype Non-Invasive Blood Glucose Measurement Systems Compared to a Standard (Invasive) Measurement Method of Blood Glucose 58

Alertgy Inc Pipeline Products & Ongoing Clinical Trials Overview 59

Alertgy NICGM – Product Status 59

Alertgy NICGM – Product Description 59

ALR Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 60

Bluetooth Enabled Complementary Blood Glucose Meter – Product Status 60

Bluetooth Enabled Complementary Blood Glucose Meter – Product Description 60

Arkal Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 61

GlucoPod CGM System – Product Status 61

GlucoPod CGM System – Product Description 61

Azurite Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 62

Blood Glucose Sensor – Product Status 62

Blood Glucose Sensor – Product Description 62

Bar-Ilan University Pipeline Products & Ongoing Clinical Trials Overview 63

Biometric Watch – Product Status 63

Biometric Watch – Product Description 63

Baylor University Pipeline Products & Ongoing Clinical Trials Overview 64

Portable Non-Invasive Blood Glucose Monitor – Product Status 64

Portable Non-Invasive Blood Glucose Monitor – Product Description 64

Biofi Medical Healthcare Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 65

Non-Invasive Blood Glucometer – Product Status 65

Non-Invasive Blood Glucometer – Product Description 65

BioGliko Sp zoo Pipeline Products & Ongoing Clinical Trials Overview 66

Glucomfort – Product Status 66

Glucomfort – Product Description 66

Biolinq Inc Pipeline Products & Ongoing Clinical Trials Overview 67

Intelligent Continuous Glucose Monitoring System – Product Status 67

Intelligent Continuous Glucose Monitoring System – Product Description 67

Biopeak Corp Pipeline Products & Ongoing Clinical Trials Overview 68

Non-Invasive Glucose Analyzer – Product Status 68

Non-Invasive Glucose Analyzer – Product Description 68

Biorasis Inc Pipeline Products & Ongoing Clinical Trials Overview 69

Glucowizzard – Product Status 69

Glucowizzard – Product Description 69

BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview 70

Smart Tattoo Glucose Sensor – Product Status 70

Smart Tattoo Glucose Sensor – Product Description 70

Biovotion AG Pipeline Products & Ongoing Clinical Trials Overview 71

VSM 3 Glucose Monitoring System – Product Status 71

VSM 3 Glucose Monitoring System – Product Description 71

Brain Beat Ltd Pipeline Products & Ongoing Clinical Trials Overview 72

Edvais – Product Status 72

Edvais – Product Description 72

Brigham and Women’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 73

Continuous Glucose Monitoring Sensor – Product Status 73

Continuous Glucose Monitoring Sensor – Product Description 73

Brighter AB Pipeline Products & Ongoing Clinical Trials Overview 74

Actiste Mini – Product Status 74

Actiste Mini – Product Description 74

CALISTO MEDICAL, INC. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 75

Glucoband – Product Status 75

Glucoband – Product Description 75

Callitas Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 76

Electronic Mosquito – Product Status 76

Electronic Mosquito – Product Description 76

Cardiff University Pipeline Products & Ongoing Clinical Trials Overview 77

Non-Invasive Blood Glucose Meter – Product Status 77

Non-Invasive Blood Glucose Meter – Product Description 77

CGM3 Ltd Pipeline Products & Ongoing Clinical Trials Overview 78

Miniaturized Implantable Continuous Glucose Monitor – Product Status 78

Miniaturized Implantable Continuous Glucose Monitor – Product Description 78

Cirtec Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 79

Blood Glucose Monitor – Product Status 79

Blood Glucose Monitor – Product Description 79

City, University of London Pipeline Products & Ongoing Clinical Trials Overview 80

Non-Invasive Glucose Monitor – Product Status 80

Non-Invasive Glucose Monitor – Product Description 80

Columbia University Pipeline Products & Ongoing Clinical Trials Overview 81

Wearable Continuous Blood Glucose Monitoring Device – Product Status 81

Wearable Continuous Blood Glucose Monitoring Device – Product Description 81

ConvaTec Group Plc Pipeline Products & Ongoing Clinical Trials Overview 82

Closed Loop Continuous Glucose Monitoring System – Product Status 82

Closed Loop Continuous Glucose Monitoring System – Product Description 82

Co-Optical Inc Pipeline Products & Ongoing Clinical Trials Overview 83

Co-Optical Device – Product Status 83

Co-Optical Device – Product Description 83

Cyber Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 84

Cybersensors Continuous Glucose Sensor – Product Status 84

Cybersensors Continuous Glucose Sensor – Product Description 84

DexCom Inc Pipeline Products & Ongoing Clinical Trials Overview 85

Dexcom 15 Day Wear Sensor – Product Status 85

Dexcom 15 Day Wear Sensor – Product Description 86

DexCom CGM With Accu-Chek Insulin Delivery System – Product Status 86

DexCom CGM With Accu-Chek Insulin Delivery System – Product Description 86

Dexcom G7 CGM System – Product Status 87

Dexcom G7 CGM System – Product Description 88

Dexcom Hospital Continuous Glucose Monitoring System – Product Status 88

Dexcom Hospital Continuous Glucose Monitoring System – Product Description 89

First-Gen Verily Sensor – Product Status 89

First-Gen Verily Sensor – Product Description 89

DexCom Inc – Ongoing Clinical Trials Overview 90

DexCom CGM With Accu-Chek Insulin Delivery System – Evaluation of a Closed-loop System for the Treatment of Type 2 Diabetes at Home (DT2_2) 91

DiaMonTech GmbH Pipeline Products & Ongoing Clinical Trials Overview 92

D-Band – Product Status 92

D-Band – Product Description 92

D-Pocket – Product Status 93

D-Pocket – Product Description 93

DirectSens GmbH Pipeline Products & Ongoing Clinical Trials Overview 94

Glucose Sensor – Product Status 94

Glucose Sensor – Product Description 94

Echo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 95

Display – Continuous Glucose Monitoring – Product Status 95

Display – Continuous Glucose Monitoring – Product Description 95

Gen 2 Symphony CGM System – Product Status 96

Gen 2 Symphony CGM System – Product Description 96

SENSOR – New Flexible Glucose Sensor & Transmitter – Product Status 96

SENSOR – New Flexible Glucose Sensor & Transmitter – Product Description 97

Symphony tCGM System – Home – Product Status 97

Symphony tCGM System – Home – Product Description 97

Symphony tCGM System – Hospital Critical Care – Product Status 98

Symphony tCGM System – Hospital Critical Care – Product Description 98

Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview 99

Viscosimetric Glucose Sensor – Product Status 99

Viscosimetric Glucose Sensor – Product Description 99

eLutions Integrated Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 100

Optically-Efficient Miniaturized Raman Optical System – Product Status 100

Optically-Efficient Miniaturized Raman Optical System – Product Description 100

Emperra GmbH E-Health Technologies Pipeline Products & Ongoing Clinical Trials Overview 101

GSM Enabled Blood Glucose Meter – Product Status 101

GSM Enabled Blood Glucose Meter – Product Description 101

EyeSense GmbH Pipeline Products & Ongoing Clinical Trials Overview 102

FiberSense System – Product Status 102

FiberSense System – Product Description 102

EyeSense GmbH – Ongoing Clinical Trials Overview 103

FiberSense System – Effectiveness and Safety Study of the Continuous Glucose Monitoring System for Home Use (Including In-clinic Sessions) in Patients with Diabetes 104

FiberSense System – Effectiveness and Safety Study of the Percutaneous Optical Fibre Glucose Sensor (FiberSense) for Home Use in Diabetic and Prediabetic Individuals 104

FiberSense System – Effectiveness and Safety Study to Investigate the Improved FiberSense Continuous Glucose Monitoring System in Diabetic Patients 104

Firefly Health Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 105

FireFly – Product Status 105

FireFly – Product Description 105

Flowsion A/S Pipeline Products & Ongoing Clinical Trials Overview 106

Glycostat – Product Status 106

Glycostat – Product Description 106

Gili Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 107

Diawatch – Product Status 107

Diawatch – Product Description 107

Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 108

Continuous Glucose Monitoring Device – Product Status 108

Continuous Glucose Monitoring Device – Product Description 108

GlucoLight Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 109

SENTRIS-100 – Product Status 109

SENTRIS-100 – Product Description 109

GlucoMe Ltd Pipeline Products & Ongoing Clinical Trials Overview 110

GlucoMe Glucose Monitoring Device – Product Status 110

GlucoMe Glucose Monitoring Device – Product Description 110

Glucometrix AG Pipeline Products & Ongoing Clinical Trials Overview 111

Non-Invasive Blood Glucose Monitoring Device – Product Status 111

Non-Invasive Blood Glucose Monitoring Device – Product Description 111

GlucoModicum Oy Pipeline Products & Ongoing Clinical Trials Overview 112

Talisman – Product Status 112

Talisman – Product Description 112

Glucorecs Pipeline Products & Ongoing Clinical Trials Overview 113

GluFit – Product Status 113

GluFit – Product Description 113

GlucoRx Ltd Pipeline Products & Ongoing Clinical Trials Overview 114

GlucoRx BioXensor – Product Status 114

GlucoRx BioXensor – Product Description 114

Glucosat Pipeline Products & Ongoing Clinical Trials Overview 115

Glucosat – Product Status 115

Glucosat – Product Description 115

Glucosense Diagnostics Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 116

Non-Invasive Blood Glucose Monitor – Product Status 116

Non-Invasive Blood Glucose Monitor – Product Description 116

Non-Invasive Blood Glucose Monitor – Finger-touch Version – Product Status 117

Non-Invasive Blood Glucose Monitor – Finger-touch Version – Product Description 117

GlucoSet AS Pipeline Products & Ongoing Clinical Trials Overview 118

GlucoSet Sensor – Product Status 118

GlucoSet Sensor – Product Description 118

GlucoStats System Pte Ltd. Pipeline Products & Ongoing Clinical Trials Overview 119

First Generation Glucose Monitoring Device – Product Status 119

First Generation Glucose Monitoring Device – Product Description 119

Second Generation Glucose Monitoring Device – Product Status 120

Second Generation Glucose Monitoring Device – Product Description 120

GlucoTrack Inc Pipeline Products & Ongoing Clinical Trials Overview 121

GlucoTrack – DF-C – Product Status 121

GlucoTrack – DF-C – Product Description 122

GlucoTrack – DF-D – Product Status 122

GlucoTrack – DF-D – Product Description 122

GlucoTrack – DF-I – Product Status 123

GlucoTrack – DF-I – Product Description 123

GlucoTrack – DF-N – Product Status 123

GlucoTrack – DF-N – Product Description 124

GlucoTrack – DF-P – Product Status 124

GlucoTrack – DF-P – Product Description 124

GlucoTrack DF-F – Product Status 125

GlucoTrack DF-F – Product Description 125

Glucovation Inc Pipeline Products & Ongoing Clinical Trials Overview 126

GW Wearable Glucose Sensor – Product Status 126

GW Wearable Glucose Sensor – Product Description 126

GluMetrics Inc Pipeline Products & Ongoing Clinical Trials Overview 127

GluCath Intravascular Continuous Glucose Monitor – Product Status 127

GluCath Intravascular Continuous Glucose Monitor – Product Description 127

Glusense Ltd Pipeline Products & Ongoing Clinical Trials Overview 128

Glyde CGM – Product Status 128

Glyde CGM – Product Description 128

Glusense Ltd – Ongoing Clinical Trials Overview 129

Glyde CGM – A Study to Evaluate the Safety and Efficacy of the GluSense’s Glyde CGM Technology in Humans 130

GlySens Inc Pipeline Products & Ongoing Clinical Trials Overview 131

Eclipse 3 ICGM System – Product Status 131

Eclipse 3 ICGM System – Product Description 131

Eclipse ICGM System – Product Status 132

Eclipse ICGM System – Product Description 132

Second Generation ICGM System – Product Status 132

Second Generation ICGM System – Product Description 133

GlySens Inc – Ongoing Clinical Trials Overview 134

Eclipse 3 ICGM System – Feasibility Trial to Evaluate the Eclipse 3 Continuous Glucose Monitoring System for Individuals with Type 1 Diabetes Mellitus – Australia (FREE – AU Trial) 135

G-Sense Ltd. Pipeline Products & Ongoing Clinical Trials Overview 136

G-Sense Device – Product Status 136

G-Sense Device – Product Description 136

Guangzhou Powder Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview 137

Continuous Glucose Monitoring System – Product Status 137

Continuous Glucose Monitoring System – Product Description 137

Guided Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 138

Altea MicroPor Laser – Product Status 138

Altea MicroPor Laser – Product Description 138

Hagar Tech Pipeline Products & Ongoing Clinical Trials Overview 139

GWave – Product Status 139

GWave – Product Description 139

GWave 2.0 – Product Status 140

GWave 2.0 – Product Description 140

Hagar Tech – Ongoing Clinical Trials Overview 141

GWave – Study to Evaluate the Accuracy of GWave in Patients with Type 1 and Type 2 diabetes in Israel 142

Helo Corp Pipeline Products & Ongoing Clinical Trials Overview 143

Helo LX Pro – Product Status 143

Helo LX Pro – Product Description 143

iGlyko, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 144

iGlyko System – Product Status 144

iGlyko System – Product Description 144

Indigo Diabetes NV Pipeline Products & Ongoing Clinical Trials Overview 145

Continuous Multi-Metabolite Monitoring Sensor – Product Status 145

Continuous Multi-Metabolite Monitoring Sensor – Product Description 145

InLight Solutions Inc. Pipeline Products & Ongoing Clinical Trials Overview 146

Non-Invasive Glucose Measurement System – Product Status 146

Non-Invasive Glucose Measurement System – Product Description 146

Innopharmax Inc Pipeline Products & Ongoing Clinical Trials Overview 147

P12001 – Product Status 147

P12001 – Product Description 147

Innovosens AB Pipeline Products & Ongoing Clinical Trials Overview 148

Diabetic Sensor – Continuous Glucose Monitoring – Product Status 148

Diabetic Sensor – Continuous Glucose Monitoring – Product Description 148

Integrated Medical Sensors Pipeline Products & Ongoing Clinical Trials Overview 149

Implantable Continuous Glucose Monitor – Product Status 149

Implantable Continuous Glucose Monitor – Product Description 149

IntelliDx Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 150

Optimus – Product Status 150

Optimus – Product Description 150

InventHelp Pipeline Products & Ongoing Clinical Trials Overview 151

Meter Reader – Product Status 151

Meter Reader – Product Description 151

Invivomon Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 152

Smart IV – Glucose Monitoring System – Product Status 152

Smart IV – Glucose Monitoring System – Product Description 152

Invivosense ASA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 153

IvSCGM Biosensor – Product Status 153

IvSCGM Biosensor – Product Description 153

I-Sens Inc Pipeline Products & Ongoing Clinical Trials Overview 154

CareSens Air Glucose Monitoring System – Product Status 154

CareSens Air Glucose Monitoring System – Product Description 154

Continuous Blood Glucose Meter – Product Status 155

Continuous Blood Glucose Meter – Product Description 155

iSense Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 156

iSense CGM – Product Status 156

iSense CGM – Product Description 156

Jiangsu Yuyue Medical Equipment & Supply Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 157

Second-Generation CGM System – Product Status 157

Second-Generation CGM System – Product Description 157

KeenCAT Technologies Pipeline Products & Ongoing Clinical Trials Overview 158

GlucoCAT – Product Status 158

GlucoCAT – Product Description 158

Keratin Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 159

Illume – Product Status 159

Illume – Product Description 159

Know Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 160

KnowU – Product Status 160

KnowU – Product Description 160

UBAND – Product Status 161

UBAND – Product Description 161

KTH Royal Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 162

Microneedle Patch – Glucose Monitoring – Product Status 162

Microneedle Patch – Glucose Monitoring – Product Description 162

Lein Applied Diagnostics Limited Pipeline Products & Ongoing Clinical Trials Overview 163

One Look – Product Status 163

One Look – Product Description 163

LEMM Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 164

Non-Invasive Blood Glucose Monitor – Product Status 164

Non-Invasive Blood Glucose Monitor – Product Description 164

Lifecare AS Pipeline Products & Ongoing Clinical Trials Overview 165

Sencell Osmotic Pressure Sensor – Product Status 165

Sencell Osmotic Pressure Sensor – Product Description 165

LifeScan Inc Pipeline Products & Ongoing Clinical Trials Overview 166

CGM Sensor – Product Status 166

CGM Sensor – Product Description 166

Next Generation OneTouch UltraVue Verio Platform Glucose Testing System – Product Status 167

Next Generation OneTouch UltraVue Verio Platform Glucose Testing System – Product Description 167

Light Touch Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 168

Mobile Blood Glucose Sensor – Product Status 168

Mobile Blood Glucose Sensor – Product Description 168

LighTouch Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 169

LighTouch Glucose Monitor – Product Status 169

LighTouch Glucose Monitor – Product Description 169

LighTouch Medical, Inc. – Ongoing Clinical Trials Overview 170

LighTouch Glucose Monitor – In Vivo Raman Spectroscopy (IVRS) of Human Fingertip Capillary Beds 171

Luminous Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 172

Argus Glucose Monitoring System – Product Status 172

Argus Glucose Monitoring System – Product Description 172

Lyte Labs Pipeline Products & Ongoing Clinical Trials Overview 173

Wearable Smart Ring – Product Status 173

Wearable Smart Ring – Product Description 173

Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 174

Implantable Glucose Sensor – Product Status 174

Implantable Glucose Sensor – Product Description 174

Non-Invasive Blood Glucose Monitor – Product Status 175

Non-Invasive Blood Glucose Monitor – Product Description 175

Medical Wireless Sensing Ltd Pipeline Products & Ongoing Clinical Trials Overview 176

GlucoWiSe – Product Status 176

GlucoWiSe – Product Description 176

Medtronic MiniMed Inc Pipeline Products & Ongoing Clinical Trials Overview 177

Combo Set Glucose Monitoring System – Product Status 177

Combo Set Glucose Monitoring System – Product Description 177

Comfort Sensor – Product Status 178

Comfort Sensor – Product Description 178

Harmony 1 Sensor – Product Status 178

Harmony 1 Sensor – Product Description 178

Harmony 2 Sensor – Product Status 179

Harmony 2 Sensor – Product Description 179

iPro 3 Glucose Monitoring System – Product Status 179

iPro 3 Glucose Monitoring System – Product Description 180

ipro 4 Glucose Monitoring System – Product Status 180

ipro 4 Glucose Monitoring System – Product Description 180

ipro 5 Glucose Monitoring System Sensor – Product Status 181

ipro 5 Glucose Monitoring System Sensor – Product Description 181

NexSensor – Product Status 181

NexSensor – Product Description 182

Simplera CGM Sensor – Product Status 182

Simplera CGM Sensor – Product Description 182

Unity Sensor – Product Status 183

Unity Sensor – Product Description 183

Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 184

Guardian 4 Sensor – Product Status 184

Guardian 4 Sensor – Product Description 184

Medtronic Plc – Ongoing Clinical Trials Overview 185

Guardian 4 Sensor – InPen User Experience 186

Mellitor Ltd Pipeline Products & Ongoing Clinical Trials Overview 187

Mellitor Sensor – Product Status 187

Mellitor Sensor – Product Description 187

Metronom Health Inc Pipeline Products & Ongoing Clinical Trials Overview 188

CGM System – Product Status 188

CGM System – Product Description 188

MicroTech Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 189

AiDex G7 – Child And Adolescent Use – Product Status 189

AiDex G7 – Child And Adolescent Use – Product Description 189

AiDex X – Product Status 190

AiDex X – Product Description 190

Exactive Pro System – Product Status 190

Exactive Pro System – Product Description 191

MicroTech Medical Co Ltd – Ongoing Clinical Trials Overview 192

AiDex G7 – Child And Adolescent Use – Clinical Trial of Continuous Glucose Monitoring System Used in Pediatric Subjects with Diabetes Mellitus 193

mobiLIFE Pipeline Products & Ongoing Clinical Trials Overview 194

GlucoReader – Product Status 194

GlucoReader – Product Description 194

Mologic Ltd Pipeline Products & Ongoing Clinical Trials Overview 195

ACuTEGA – Product Status 195

ACuTEGA – Product Description 195

Movano Inc Pipeline Products & Ongoing Clinical Trials Overview 196

Movano Ring – Product Status 196

Movano Ring – Product Description 196

Nagasaki University Pipeline Products & Ongoing Clinical Trials Overview 197

Tabletop Blood-Glucose Meter – Product Status 197

Tabletop Blood-Glucose Meter – Product Description 197

Nemaura Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 198

sugarBEAT – Product Status 198

sugarBEAT – Product Description 199

Nemaura Medical Inc – Ongoing Clinical Trials Overview 200

sugarBEAT – Study is to Compare the sugarBEAT and Major Continuous Glucose Monitor Sensor in People with Diabetes 201

Newton Photonics Inc Pipeline Products & Ongoing Clinical Trials Overview 202

Non-invasive Blood Glucose Monitor – Product Status 202

Non-invasive Blood Glucose Monitor – Product Description 202

NIR Diagnostics Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 203

GlucoNIR – Product Status 203

GlucoNIR – Product Description 203

Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 204

Continuous Glucose Sensor – Product Status 204

Continuous Glucose Sensor – Product Description 204

Occuity Ltd Pipeline Products & Ongoing Clinical Trials Overview 205

Occuity Indigo Glucose Monitor – Product Status 205

Occuity Indigo Glucose Monitor – Product Description 205

Pelikan Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 206

Pelikan Blood Glucose System – Product Status 206

Pelikan Blood Glucose System – Product Description 206

Pepex Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 207

Trio One-Click Meter – Product Status 207

Trio One-Click Meter – Product Description 207

PharmaTech Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 208

GenPrecis Precision Monitoring System – Product Status 208

GenPrecis Precision Monitoring System – Product Description 208

GenUltimate TBG – Version 2 – Product Status 209

GenUltimate TBG – Version 2 – Product Description 209

GenUltimate! TBG – Product Status 209

GenUltimate! TBG – Product Description 210

PKvitality SAS Pipeline Products & Ongoing Clinical Trials Overview 211

K’Watch Glucose – Product Status 211

K’Watch Glucose – Product Description 211

PKvitality SAS – Ongoing Clinical Trials Overview 212

K’Watch Glucose – Clinical Investigation of K’Watch – Lab & Home Study 213

POPS! Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 214

Pediatric POPS! SmartMeter – Product Status 214

Pediatric POPS! SmartMeter – Product Description 214

PositiveID Corp Pipeline Products & Ongoing Clinical Trials Overview 215

Fully Synthetic Glucose Sensing System – Product Status 215

Fully Synthetic Glucose Sensing System – Product Description 215

Profusa Inc Pipeline Products & Ongoing Clinical Trials Overview 216

Non-enzymatic Glucose Sensor – Product Status 216

Non-enzymatic Glucose Sensor – Product Description 216

Provigate Inc Pipeline Products & Ongoing Clinical Trials Overview 217

Gluco Review – Clinic Use – Product Status 217

Gluco Review – Clinic Use – Product Description 217

Gluco Review – Home Use – Product Status 218

Gluco Review – Home Use – Product Description 218

Purdue University Pipeline Products & Ongoing Clinical Trials Overview 219

Hydrogel Sensor – Glucose Monitoring – Product Status 219

Hydrogel Sensor – Glucose Monitoring – Product Description 219

Soft Contact Lens – Product Status 220

Soft Contact Lens – Product Description 220

Q Step Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 221

Non-Invasive Blood Glucose Monitor – Product Status 221

Non-Invasive Blood Glucose Monitor – Product Description 221

Quantum Operation Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 222

Non-Invasive Blood Glucose Measurement Sensor – Product Status 222

Non-Invasive Blood Glucose Measurement Sensor – Product Description 222

Roche Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 223

Ilustrates – Product Status 223

Ilustrates – Product Description 223

Sangui BioTech International Inc Pipeline Products & Ongoing Clinical Trials Overview 224

Implantable Glucose Sensor – Product Status 224

Implantable Glucose Sensor – Product Description 224

Sanmina Corp Pipeline Products & Ongoing Clinical Trials Overview 225

Non-Invasive Optical Glucose Monitor – Product Status 225

Non-Invasive Optical Glucose Monitor – Product Description 225

SD Biosensor Inc Pipeline Products & Ongoing Clinical Trials Overview 226

All-In-One Next-Generation Continuous Glucose Monitoring System – Product Status 226

All-In-One Next-Generation Continuous Glucose Monitoring System – Product Description 226

Continuous Glucose Monitoring System – Product Status 227

Continuous Glucose Monitoring System – Product Description 227

Senseonics Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 228

Eversense XL CGM System – Product Status 228

Eversense XL CGM System – Product Description 228

Freedom System – Product Status 229

Freedom System – Product Description 229

Senseonics Holdings Inc – Ongoing Clinical Trials Overview 230

Eversense XL CGM System – Evaluation of Long-term Implanted Sensor in Patients on Quality of Life 231

SensiVida Medical Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 232

Glucose Monitoring System – Product Status 232

Glucose Monitoring System – Product Description 232

Sensys Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 233

Sensys GTS – Product Status 233

Sensys GTS – Product Description 233

Sentec Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 234

NoStrip Blood Glucose Meter – Product Status 234

NoStrip Blood Glucose Meter – Product Description 234

Shenzhen Refresh Biosensing Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 235

CGM Sensor – Product Status 235

CGM Sensor – Product Description 235

Shenzhen Sibionics Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 236

SIBIONICS CGM – Product Status 236

SIBIONICS CGM – Product Description 236

Shield Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 237

Fully Integrated Smartphone Glucometer – Product Status 237

Fully Integrated Smartphone Glucometer – Product Description 237

Singapore Biomicro Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 238

Implantable Blood Glucose Monitoring Device – Product Status 238

Implantable Blood Glucose Monitoring Device – Product Description 238

Socrates Health Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 239

Companion CM – Product Status 239

Companion CM – Product Description 239

Companion LS – Product Status 240

Companion LS – Product Description 240

Companion SR – Product Status 240

Companion SR – Product Description 241

Solys Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 242

Non-Invasive Blood Glucose Measuring Device – Product Status 242

Non-Invasive Blood Glucose Measuring Device – Product Description 242

Spire Biophotonics Lifesciences Pipeline Products & Ongoing Clinical Trials Overview 243

Non-Invasive Glucose Monitor – Product Status 243

Non-Invasive Glucose Monitor – Product Description 243

St. Louis Medical Devices Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 244

Non-Invasive Blood Glucose Detector – Product Status 244

Non-Invasive Blood Glucose Detector – Product Description 244

Stony Brook University Pipeline Products & Ongoing Clinical Trials Overview 245

GlucoREAD Patch – Product Status 245

GlucoREAD Patch – Product Description 245

Swansea University Pipeline Products & Ongoing Clinical Trials Overview 246

Flash Glucose Monitoring Device – Product Status 246

Flash Glucose Monitoring Device – Product Description 246

Hi-Tech Diabetes Blood Glucose Monitor – Product Status 247

Hi-Tech Diabetes Blood Glucose Monitor – Product Description 247

Tandem Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 248

Next Generation Closed Loop – Product Status 248

Next Generation Closed Loop – Product Description 248

TecMed Inc Pipeline Products & Ongoing Clinical Trials Overview 249

Surgical Suite Unit – Product Status 249

Surgical Suite Unit – Product Description 249

Tenax Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 250

Glucose Biosensor – Product Status 250

Glucose Biosensor – Product Description 250

Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 251

CMOS Image Glucose Sensor – Product Status 251

CMOS Image Glucose Sensor – Product Description 252

Texas A&M University Pipeline Products & Ongoing Clinical Trials Overview 253

Figures

Blood Glucose Meters – Pipeline Products by Stage of Development 25

Blood Glucose Meters – Pipeline Products by Segment 26

Blood Glucose Meters – Pipeline Products by Territory 27

Blood Glucose Meters – Pipeline Products by Regulatory Path 29

Blood Glucose Meters – Pipeline Products by Estimated Approval Date 30

Blood Glucose Meters – Ongoing Clinical Trials 31

Frequently asked questions

Blood Glucose Meters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Blood Glucose Meters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Blood Glucose Meters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Blood Glucose Meters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.